Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
North Star Brands LLC maintains a patent portfolio focused on the Biotechnology & Pharmaceuticals technology area. The current prosecution landscape is characterized by a single point of activity, with 1 pending office action reported. This activity is distributed across 1 distinct examiner and 1 distinct art unit, representing a narrow channel of engagement with the patent office.
CHI, AMANDA LYNN serves as the busiest examiner for the portfolio, currently responsible for 1 pending office action. Because the total number of pending office actions is 1, this examiner handles the entirety of the company's active patent challenges. This structure suggests that the company's immediate legal focus is limited to a specific pharmaceutical or biotechnological innovation rather than a broad array of diverse filings.
The reliance on 1 distinct examiner within 1 distinct art unit means that the prosecution strategy is highly sensitive to the individual tendencies of CHI, AMANDA LYNN. Practitioners should note that the lack of multiple art units or examiners reduces the complexity of managing different examiner styles. However, it also means that the success of the current Biotechnology & Pharmaceuticals portfolio hinges on the resolution of this 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHI, AMANDA LYNN | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18648246 | BEVERAGE TABLET AND METHOD OF CUSTOMIZING AN AQUEOUS BEVERAGE USING THE SAME | CHI, AMANDA LYNN | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18648246 | BEVERAGE TABLET AND METHOD OF CUSTOMIZING AN AQUEOUS BEVERAGE USING THE SAME | CHI, AMANDA LYNN | 1613 | §102§103 | Non-Final OA | — | Pending | Apr 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNorth Star Brands LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Amanda Lynn Chi has the most, with 1 of North Star Brands LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
